Finally, we investigated whether TMEM175 mutations might affect the amount and distribution of glucosylceramide (GlcCer), which is cleaved into glucose and ceramide by the lysosomal enzyme glucocerebrosidase (GBA), as well as the expression of ganglioside GM1, which is reduced in PD patients [35]. This evidence concerns the gene GBA1 and Parkinson disease.